Skip to main content

Advertisement

Table 1 Baseline demographics of study population

From: Evaluation of the relationship between circulating omentin-1 concentrations and components of the metabolic syndrome in adults without type 2 diabetes or cardiovascular disease

Characteristic Total population (n = 93) Metabolic syndrome (n = 65) No metabolic syndrome (n = 28) a P value
Omentin-1 (ng/mL) 149.2 ± 72.7 145.7 ± 70.0 157.4 ± 79.3 0.50
Sex (women/men) 47/46 32/33 15/13 0.70
Age (years) 48 ± 8 49 ± 8 45 ± 8 0.02
Current smokers 24 (25.8%) 16 (24.6%) 8 (12.3%) 0.69
BMI (kg/m2) 31.3 ± 4.7 32.1 ± 4.0 29.3 ± 5.6 0.02
Weight (kg) 91.6 ± 15.6 93.8 ± 13.4 86.4 ± 19.2 0.01
Systolic blood pressure (mm Hg) 129 ± 14 132 ± 14 121 ± 12 0.001
Diastolic blood pressure (mm Hg) 83 ± 12 85 ± 11 77 ± 13 0.002
Waist circumference (cm) 106.0 ± 11.8 108.6 ± 9.5 99.9 ± 14.4 0.001
Fasting plasma glucose (mg/dL) 93 ± 9 95 ± 10 89 ± 8 0.001
Impaired fasting glucose 28 (30.1%) 26 (40.0%) 2 (7.1%) 0.002
Total cholesterol (mg/dL) 187 ± 35 187 ± 37 185 ± 30 0.73
LDL cholesterol (mg/dL) 110 ± 29 109 ± 30 111 ± 25 0.80
HDL cholesterol (mg/dL) 44 ± 11 41 ± 10 50 ± 12 <0.001
Triglycerides (mg/dL) 166 ± 83 187 ± 80 118 ± 71 <0.001
White blood cell count (x 109/L) 6.5 ± 2.0 6.4 ± 1.8 6.7 ± 2.4 0.60
  1. Data are expressed as mean ± standard deviation or number (%). aP values are for comparisons of metabolic syndrome versus no metabolic syndrome. Plasma omentin-1 concentrations, expressed as median (interquartile range), were 137.2 ng/ml (94.2 to 186.8 ng/ml) in the total population, 133.1 ng/ml (93.5 to 184.8 ng/ml) in participants with the metabolic syndrome, and 137.4 ng/ml (104.5 to 196.2 ng/ml) in participants without the metabolic syndrome.